Cost-effectiveness of drug-eluting stents versus bare-metal stents in patients undergoing percutaneous coronary intervention

Objective To describe the initial experience with direct implantation of a CoreValveTM selfexpanding aortic valve prosthesis in a tertiary cardiovascular care center from Argentina. Methods From May to December 2010, 21 consecutive patients with severe aortic stenosis (SAS) and high surgical riskwere included to undergo percutaneous aortic valve replacement with a CoreValveTM prosthesis. The inclusion criteria were the following: aortic valve area <1 cm2 (<0.6 cm2/m2); aortic annulus diameter of 20- 27 mm; ascending aorta diameterat the level of the sinotubular junction ≤ 40 (small prosthesis) or ≤ 43 mm (large prosthesis), and femoral artery diameter >6 mm.

• Autores: Ortiz Sierra, María Clara; Cepeda Gil, Magda C. Ristiana; Carrillo Gómez, Diana Cristina; Guevara Cuéllar, César Augusto
• Tipo de recurso: Article of investigation
• Fecha de publicación: 2012
• Institución: Universidad ICESI
• Repositorio: Repositorio ICESI
• Idioma: spa
• OAI Identifier: oai:repository.icesi.edu.co:10906/80878
• Acceso en línea: http://www.sac.org.ar/wp-content/uploads/2014/04/2918.pdf; http://hdl.handle.net/10906/80878; http://dx.doi.org/10.7775/rac.es.v80.i5.1024
• Palabra clave: Ciencias socio biomédicas; Medical sciences; Cardiovascula; Sistemas de salud - Argentina; Enfermedades coronarias
• Rights: openAccess
• License: https://creativecommons.org/licenses/by-nc-nd/4.0/